A dihydropyridone-mediated approach to the morphine skeleton was investigated. The hexahydroisoquinoline 2 was synthesized in 9 steps using N-acylpyridinium chemistry and dihydropyridone functionalization methods. This new approach should be useful in the design of more efficient syntheses of morphine and its derivatives.
Introduction
Morphine (1) has been a target for total synthesis since its structure elucidation by Robinson in 1925. Many routes have been explored and are reported in the literature. 1 The rigidity of morphinans along with the axial orientation of the C9 substituent prompted us to investigate a new approach using asymmetric N-acylpyridinium salt chemistry. 2 The synthesis of intermediate hexahydroisoquinoline 2 was obtained in 9 linear steps from readily available materials and is reported herein along with an alternate route explored leading to spiro compound 3 (Fig. 1) . 
Results and discussion
Chiral N-acylpyridinium salt chemistry has been extensively investigated in our laboratory.
2 Introduction of a substituent adjacent to the nitrogen atom of pyridine can be done stereoselectively by treatment of a chiral pyridinium salt with a Grignard or other organometallic reagent. Following an acidic workup, dihyropyridones are obtained in high yield and high diastereomeric ratio. An additional feature of this methodology is the presence of A (1, 3) strain between the carbamate group and the newly introduced C2 appendage. Consequently, the latter adopts preferentially an axial orientation. The target disconnection that would be amenable to this methodology in the case of morphine is the axial C9-C10 bond (Fig. 1) . Bicyclic intermediate 2 was an initial target since it contains all the non-methyl carbon atoms present in morphine. Besides, structures similar to 2 have been converted into morphinans in the past. 3 The synthesis of hexahydroisoquinoline 2 was initiated by the reaction of Grignard reagent 5 4 with the preformed salt of 3-triisopropylsilyl-4-methoxypyridine and (+/-)-trans-2-(-cumyl)cyclohexyl chloroformate (TCC chloroformate) (Scheme 1). Upon acidic workup, a good yield (88%) of pure dihydropyridone 6 was obtained with excellent diastereoselectivity (92% de). Racemic TCC chloroformate was used in this preliminary study; however, both antipodes of the chloroformate are accessible by enzymatic resolution of the racemic alcohol precursor. Based upon previous studies in our laboratory, the use of the (-)-enantiomer of TCC chloroformate would lead to the desired absolute stereochemistry of natural morphine.
2 Exposure of the highly encumbered dihydropyridone 6 to one equivalent of bromine lead to the selective halogenation of the aromatic ring para to the benzyloxy group. 5 No halogenation was observed on the dihydropyridone ring. At this stage the chiral auxiliary was removed by treatment under basic conditions and recovered in near quantitative yield. The triisopropyl group was no longer needed as well and was removed under acidic conditions. Reprotection of the free amine 8 was accomplished either with benzyl or phenyl chloroformate.
Various conditions were then explored for the synthesis of compound 2. Initially, it was thought that a Robinson annulation on dihydropyridone 9 would give rise directly to a tetrahydroisoquinoline intermediate. 6 Unfortunately, no alkylation at the C3 position of dihydropyridone 9 was observed. Formation of a silyl enol ether of compound 9 also failed to give alkylation products upon reaction with methyl vinyl ketone.
7 A slightly longer route was then envisioned. It involved the use of a strong electrophile such as 3-butenyltriflate. Under those conditions, alkylation of the C3 position of dihydropyridone 9 was observed in 43% yield. 8 An equal quantity of starting material was recovered along with the expected product 10. Scheme 1. a) toluene, THF, -78 °C, 88%, 85% de; b) AcOH, AcONa, Br 2 , 86%; c) MeONa, EtOH, reflux, followed by 10% HCl, 100%; d) LDA, THF, -78 °C then benzyl chloroformate (9a, 81%) or phenyl chloroformate (9b, 85%); e) KHMDS, THF, -78 °C then 3-butenyl triflate, 10a (42%) or 10b (37%) At this point, an alternative approach was investigated. It aimed at the activation of the C3 position towards alkylation (Scheme 2). Enol 11 was obtained in good yield (86%) by deprotonation with sodium bis(trimethylsilyl)amide followed by treatment with trifluoroethylformate. 9 Compound 11 reacted smoothly under mildly basic conditions to afford the highly substituted dihydropyridone 12 in good yield (88%). 10 At this stage, various reduction conditions were attempted to obtain the piperidone ring. Unfortunately, the presence of the reactive carbonyl groups in compound 12 prevented the transformation. Obtaining the piperidone intermediate was critical to the success of this route. Indeed, cyclization of dihydropyridone 12 under acidic conditions yielded spiro compound 3 exclusively. The difference in electrophilicity between the aldehyde group and the C4 carbonyl moiety of the vinylgous amide accounts for this result. Reduction of the dihydropyridone to the piperidone ring was needed to remove the conjugation and increase the electrophilicity of the C4 carbonyl. Basic cyclization conditions gave either retro Michael enol 11 or decomposition. The relative stereochemistry of compound 3 was assigned by NOE experiment. Irradiation of the benzylic CH 2 protons produced a positive NOE effect with the ethylenic proton of the cyclohexenone moiety (Fig. 2) . Scheme 2. a) NaHMDS, THF, -78 °C then CF 3 CH 2 CHO, 86%; b) MVK, Et 3 N, EtOAc, cat. KOH, 88%; c) TsOH, benzene, 50 °C, 70%
Figure 2. Relative stereochemistry
The initial plan was then further explored. Dihydropyridone 10b was reduced to the piperidone via a procedure previously reported by our laboratory (Scheme 3).
11 Wacker oxidation took place smoothly to afford diketo compound 14. 12 The relative stereochemistry of this compound was also determined by an NOE experiment and confirmed to be trans (Fig. 2) . As expected, molecular mechanics (MMFF) indicated that the C2, C3 substituents of 14 were trans diaxial due to A (1, 3) strain. 2d Irradiation of the CH 2 group attached to the C3 position yielded a positive NOE effect with the proton adjacent to the nitrogen atom. The desired relative stereochemistry being cis, we were hoping that epimerization would occur under the subsequent basic cyclization conditions. Prior estimation of the energy of the conformer distribution of both the trans and the cis compounds indicated that the cis compound was thermodynamically favored by a few kcal/mol. Diketone 14 was treated with base to yield tertiary alcohol 16 as a 3:1 inseparable mixture of isomers. 13 The cyclization initially proceeded via the complete conversion of 14 to isolable bicyclononane compound 15. Extended reaction times, however, afforded the complete disappearance of the bicyclononane to yield the expected octahydroisoquinoline 16. No elimination was observed under these reaction conditions. However, dehydration occurred upon treatment with acid to afford compounds 2 and 17 in 23% and 13% yield, respectively, along with 27% of the major isomer of alcohol 16. The relative stereochemistry of minor compound 17 was confirmed to be trans by X-ray analysis (Scheme 4). Careful monitoring of the dehydration reaction revealed that the minor isomer of alcohol 16 reacted first to produce compound 17. Desired compound 2 formed more slowly and originated from the major isomer of alcohol 16. Dehydration of the recovered alcohol 16 would lead to a combined 50% of the desired hexahydroisoquinoline 2. This observation suggests that epimerization of the C3 position to the desired cis configuration in 2 took place during the cyclization step. 
Conclusions
In summary, hexahydroisoquinoline 2 was successfully synthesized via Nacylpyridinium salt chemistry. Hexahydroisoquinoline 2 represents a potential intermediate in the synthesis of (-)-morphine (1). All the non-methyl carbon atoms of morphine are present in compound 2. Although the relative stereochemistry between the C2 and C3 carbons of compounds 10, 13 and 14 was opposite to the required one, epimerization took place during the basic cyclization to afford the desired cis-hexahydroisoquinoline 2 as the major product. A racemic mixture of TCC chloroformate was used in this initial study; however, either enantiomer is available and the (-)-enantiomer of TCC chloroformate would lead to the absolute stereochemistry present in natural morphine.
Experimental

General methods
All reactions were performed in oven-dried glassware under a nitrogen or argon atmosphere and stirred magnetically. THF and ether were distilled from sodium/benzophenone ketyl prior to use. Toluene was distilled from sodium. Triethylamine, diisopropylamine, and CH 2 Cl 2 were distilled from calcium hydride and stored under argon over 4 Å molecular sieves. n-Butyllithium was titrated against biphenylmethanol. Sodium bis(trimethylsilyl)amide was titrated against 9-methylfluorene following the procedure reported by Mash and coworkers.
14 Other reagents and solvents from commercial sources were stored under argon and used directly. Melting points were measured on a Thomas-Hoover capillary melting point apparatus and are uncorrected. Radial preparative layer chromatography (radial PLC) was performed on a Chromatotron (Harrison Associates, Palo Alto, CA) using glass plates coated with 1, 2 or 4 mm layers of Kieselgel 60 PF254 containing gypsum. High-resolution mass spectral analysis (HRMS) was performed at North Carolina State University. NMR spectra were obtained using a Varian Gemini GN-300 (300 MHz), Varian Mercury 300 (300 MHz) or Varian Mercury 400 (400 MHz). Chemical shifts are in ppm units with TMS (0.0 ppm) used as the internal standard for 1 H NMR spectra and the CDCl 3 absorption of (77.23 ppm) for 13 C NMR. Certain 13 C NMR spectra display a mixture of rotamers (r) and all peaks observed are listed. IR spectra were recorded on a Perkin-Elmer 1430, MIDAC M2000, or JASCO FT/IR-410 spectrometer. X-Ray data was obtained at Wake Forest University X-Ray laboratory.
Experimental procedures
2-(5-Benzyloxy-4-methoxybenzyl)-4-oxo-5-(triisopropylsilyl)-3,4-dihydro-2H-pyridine-1-carboxylic acid 2-(1-methyl-1-phenylethyl)cyclohexyl ester (6).
To a solution of 4-methoxy-3-(triisopropylsilyl)pyridine (1.0 g, 3.78 mmol) in 38 mL of freshly distilled toluene cooled to -23 ºC was added a solution of (+/-)-TCC chloroformate (1 M in toluene, 3.78 mL). After 30 min, the solution was cooled to -78 ºC and 15 mL of THF was added. The Grignard reagent 5 (5.65 mmol) (freshly prepared by the procedure described below) was added via a jacketed cannula maintained at -78 ºC. The resulting mixture was stirred at -78 ºC for 1.5 h. The reaction mixture was quenched by the addition of 13 mL of 10% HCl and warmed to rt over a period of 1 h. After usual workup the residue was purified by flash chromatography to yield 2.41 g (88%) of the major diastereomer and 93 mg (3.4%) of the minor diastereomer: 85% de. Major isomer: IR (thin film, neat, NaCl) 2938, 2861, 1717, 1655, 1571, 1514, 1383, 1323, 1251, 1136 7, 152.3, 148.9, 148.2, 147.4, 137.4, 129.2, 128.8, 128.3, 128.1, 127.5, 125.1, 122.6, 115.9, 112.1, 110.7, 78.0, 71.4, 56.2, 53.1, 51.3, 39.5, 36.0, 33.6, 31.2, 26.9, 26.1, 24.8, 21.6, 19.1, 11.3 
4.2.2
Procedure for the preparation of 3-benzyloxy-4-methoxybenzylmagnesium chloride. To a mixture of magnesium powder (2.75 g, 75.3 mmol) in 90 mL of anhydrous THF at rt was added 1,2-dibromoethane (0.3 mL, 3.5 mmol). After stirring for 15 min, a solution of 3-benzyloxy-4-methoxybenzyl chloride (5.93 g, 22.6 mmol) in 20 mL of anhydrous THF was added over a period of 50 min at rt. After completion of the addition, the Grignard reagent was stirred for an additional 1.5 h at rt to form a light brown solution. Stirring was stopped to allow for the excess magnesium to settle and the Grignard reagent was cooled to -78°C.
4.2.3
2-(5-Benzyloxy-2-bromo-4-methoxybenzyl)-4-oxo-5-(triisopropylsilyl)-3,4-dihydro-2H-pyridine-1-carboxylic acid 2-(1-methyl-1-phenylethyl)cyclohexyl ester (7). The starting material 6 (18.11 g, 25 mmol) was placed in a 1 L flask. NaOAc (3.1 g, 37.5 mmol) and 583 mL of glacial AcOH were added. To the mixture was slowly added a solution of Br 2 (1.28 mL, 25 mmol) in 50 mL glacial AcOH. The reaction mixture was allowed to stir at rt for 8 h. Some solid precipitated out. The acetic acid was evaporated and the crude oil was dissolved in CH 2 Cl 2 , washed twice with H 2 O (120 mL) and once with brine (120 mL). The organic phase was dried with Na 2 SO 4 and concentrated in vacuo. Trituration in hexanes gave compound 7 as a white solid (16.01 g). Purification of the mother liquor by radial PLC (SiO 2 , EtOAc/hexanes) yielded an additional 1.22 g of product to bring the total amount to 17.2 g (86%). Some starting material was also recovered (1.37 g, 7.5%). Mp 159-161 ºC; IR (thin film, neat, NaCl) 2939, 2862, 1716, 1656, 1572, 1509, 1385, 1322, 1248, 1017 149.4, 147.7 and 147.5 (r), 136.8, 128.7, 128.2, 128.1, 127.6, 125.5, 125.3, 117.3, 116.2, 115.1, 110.9, 78.1, 71.2, 56.5, 51.4, 51.0, 39.9 and 39.8 (r), 35.9, 33.3, 30.0, 27.0, 26.1, 24.8, 23.0, 19.2, 11.3 
2-(5-Benzyloxy-2-bromo-4-methoxybenzyl)-2,3-dihydro-1H-pyridin-4-one (8).
The starting material 7 (208 mg, 0.26 mmol) was dissolved in 10 mL of ethanol. Sodium methoxide (0.3 mL, 25w% solution in methanol) was added and the resulting solution was stirred at reflux overnight. The solvent was removed in vacuo and THF (10 mL) was added. A 10% aqueous solution of HCl (2.33 mL) was added and the mixture was stirred for 1 h at rt and then cooled down to 0 ºC. Solid K 2 CO 3 was added carefully to the mixture. After usual workup and flash chromatography, the product 8 was obtained as a white solid (111 mg, 100%): mp 117.5-118.5 ºC; IR (thin film, neat, NaCl) 3250, 3032, 2955, 1623, 1576, 1507 1258, 1215, 1164, 1027 192.5, 150.8, 149.6, 147.2, 136.6, 128.8, 128.2, 128.0, 127.5, 117.1, 116.5, 115.3, 99.3, 71.2, 56.4, 52.8, 41.9, 39.4 Benzyloxy-2-bromo-4-methoxybenzyl)-4-oxo-3,4-dihydro-2H-pyridine-1-carboxylic acid benzyl ester (9a). Compound 8 (1.0 g, 2. 49 mmol) was dissolved in THF and cooled down to -78 ºC. A preformed solution of LDA in THF at -78 ºC (diisopropylamine, 0.522 mL, 3.73 mmol; n-BuLi, 1.5 ml, 3.73 mmol) was then added via cannula. The resulting solution was stirred for 1 h and then allowed to warm up to -40 ºC. Freshly distilled benzyl choroformate (0.426 mL, 3.00 mmol) was then quickly added and the reaction was stirred for 1.5 h at -40 ºC. The reaction mixture was quenched with a saturated aqueous solution of NaHCO 3 . After usual work up and purification of the residue by radial PLC, the product 9a was isolated as a white solid (1.08 g, 81%): mp 91-93 ºC; IR (thin film, neat, NaCl) 3032, 2931, 1725, 1669, 1603, 1504, 1327, 1259, 1216 
2-(5-
2-(5-Benzyloxy-2-bromo-4-methoxybenzyl)-4-oxo-3,4-dihydro-2H-pyridine-1-carboxylic acid phenyl ester (9b)
. The same procedure as described for the preparation of 9a was used, with phenylchloroformate. After purification by radial PLC compound 9b was obtained in 85% yield as a white solid: mp 110-112 ºC; IR (thin film, neat, NaCl) 3067, 2929, 1740, 1671, 1604, 1508, 1331, 1257, 1190, 1026 5, 149.8, 147.9, 141.0, 136.9, 129.4, 128.6, 128.0, 127.9, 127.4, 126.1, 121.0, 117.5, 116.7, 115.7, 108.4, 71.6, 56.4, 53.3, 39.8, 36 
2-(5-Benzyloxy-2-bromo-4-methoxybenzyl)-3-but-3-enyl-4-oxo-3,4-dihydro-2H-pyridine-1-carboxylic acid benzyl ester (10a).
In a flask, purged with argon, were placed 3-butenol (0.347 mL, 4 mmol), pyridine (0.323 mL, 4 mmol) and 4 mL of anhydrous hexane. In a separate flask, trifluoromethanesulfonic anhydride (0.676 mL, 4 mmol) was diluted with 4 mL of anhydrous hexane and cooled to 0 ºC. The alcohol/pyridine solution was transferred to the anhydride via cannula, and the resulting heterogeneous mixture was stirred at 0 ºC for 20 min. The precipitate was filtered and the clear, colorless filtrate was used as is, without concentration or purification. The starting material 9a (200 mg, 0.37 mmol) was placed in a separate flask. Freshly distilled THF was added (20 mL) and the resulting mixture was cooled to -78 ºC. A solution of KHMDS (3.73 mL, 1.86 mmol) was then added and the reaction mixture was stirred for 30 min at -78 ºC. The crude triflate was then added quickly to the enolate, and the reaction mixture was stirred for 4 h at -78 ºC. The reaction mixture was quenched with a saturated aqueous solution of NaHCO 3 and warmed to rt. After usual workup and purification by radial PLC, compound 10a was isolated in a 42% yield (93 mg) as an oil. Some starting material was also recovered (68 mg, 34%). IR (thin film, neat, NaCl) 3071, 2931, 1726, 1666, 1604, 1503, 1327, 1260, 1214, 1117, 1028 6, 149.8, 148.0, 140.5, 137.3, 137.1, 135.2, 128.9, 128.9, 128.8, 128.6, 128.4, 128.2, 127.6, 117.7, 116.8, 115.9, 106.4, 71.8, 69.3, 56.7 and 56.6 (r) 
4.2.8
2-(5-Benzyloxy-2-bromo-4-methoxybenzyl)-3-but-3-enyl-4-oxo-3,4-dihydro-2H-pyridine-1-carboxylic acid phenyl ester (10b). The procedure followed was the same as described for the preparation of compounds 10a. Compound 10b was obtained as an oil in 37% yield. IR (thin film, neat, NaCl) 2929, 1740, 1668, 1604, 1505, 1335, 1259, 196.4, 150.7, 150.0, 148.1, 140.2, 137.3-137.1 (r), 129.6, 128.9, 128.4, 128.2, 127.5, 126.4, 121.2, 117.7, 116.9, 116.1, 107.3, 71.9, 57.1, 56.7, 48.7, 36.5, 31.1, 30 
2-(5-Benzyloxy-2-bromo-4-methoxybenzyl)-3-hydroxymethylene-4-oxo-3,4-dihydro-2H-pyridine-1-carboxylic acid benzyl ester (11).
A solution of dihydropyridine 9a (3.41 g, 6.36 mmol) was dissolved in THF (60 mL) and cooled to -78 ºC. A solution of NaHMDS (0.7 M, 11.8 mL, 8.26 mmol) was then added and the solution was stirred at -78 ºC for 45 min. Neat trifluoroethyl formate (3.66 mL, 38.3 mmol) was rapidly added and the mixture was stirred at -78 ºC for 3 h and then warmed up to -40 ºC prior to a quench with neat H 2 SO 4 (0.636 mL). The reaction mixture was transferred to a separatory funnel with ether and water. The layers were separated, and the aqueous phase was extracted with ether. The combined organic extracts were washed with saturated aqueous NH 4 Cl, dried over MgSO 4 and concentrated in vacuo. The residual yellow oil was dissolved in ether and extracted with cold 1% aqueous NaOH. The remaining organic phase was concentrated to give the starting dihydropyridone (407 mg, 12%). The aqueous extract was acidified to pH = 1 by addition of 10% HCl and extracted with CH 2 Cl 2 . The combined organic extract were dried over MgSO 4 and concentrated in vacuo to give 11 as a yellow foam (3.07 g, 86% 9, 170.2, 150.0, 147.9, 139.6 (broad), 137.0, 135.1, 129.1, 129.0, 128.8, 128.2, 127.7, 127.3, 118.3, 116.6, 105.9, 105.7, 71.8, 69.4, 56.48, 54.5 Benzyloxy-2-bromo-4-methoxybenzyl)-3-formyl-4-oxo-3-(3-oxo-butyl)-3,4-dihydro-2H-pyridine-1-carboxylic acid benzyl ester (12) . The starting enol 11 (3.76 g, 6.65 mmol) was dissolved in 110 mL of dry EtOAc and cooled to 0 °C. Triethylamine was added (1.37 mL, 9.85 mmol) and methylvinylketone (0.828 mL, 10 mmol) followed by a catalytic amount of KOH. The reaction mixture was stirred at 0 °C for 6 h and quenched with water. The pH was adjusted to 2 with aqueous 1% HCl, and the aqueous phase was extracted with ether. The combined extracts were washed with brine and dried over MgSO 4 . Filtration and evaporation of the solvents afforded the crude diketone 12. Flash chromatography gave 3.72g (88%) of product as a white foam. IR (thin film, neat, NaCl) 2933, 1716, 1660, 1600, 1504 1298, 1217 cm 201.8, 194.2, 149.9, 147.9, 141.5, 137.1, 134.8, 128.9, 128.8, 128.5, 128.3, 128.1, 127.3, 117.3, 116.4, 105.9, 71.7, 69.4, 58.1, 56.5, 37.4, 32.7, 30.0, 27 4.2.11 1-(5-Benzyloxy-2-bromo-4-methoxybenzyl)-5,9-dioxo-2-aza-spiro[5.5]undeca-3,7-diene-2-carboxylic acid benzyl ester (3). Compound 12 (214 mg, 0.34 mmol) was placed in benzene (4 mL). To this solution was added 64 mg of p-toluenesulfonic acid. The resulting reaction mixture was stirred overnight at 50 °C. After usual workup, the residue was purified by radial PLC to yield 151 mg (70%) of compound 3 as a white solid: mp 167-168 ºC; IR (thin film, neat, NaCl) 2928, 1729, 1668, 1602, 1507, 1301, 1206 cm -1 ; 1 H NMR (CDCl 3 , 400 MHz, T = 55 °C) 9H), 2H), 6.99 (d, 1H, J = 9.6 Hz), 6.89 (broad s, 1H), 6.49 (s, 1H), 6.22 (d, 1H, J = 10.8 197.5, 195.8, 152.7, 149.4, 147.4, 141.0, 140.3, 136.9, 134.4, 131.9, 129.0, 128.9, 128.3, 128.1, 127.1, 116.6, 115.8, 106.1, 105.4, 71.5, 69.3, 58.2, 57.5, 56.4, 49.3, 33.1, 32.6, 30 4.2.12 2-(5-Benzyloxy-2-bromo-4-methoxybenzyl)-3-but-3-enyl-4-oxo-piperidine-1-carboxylic acid phenyl ester (13) . The starting dihydropyridone 10b (625 mg, 1.08 mmol) was dissolved in freshly distilled THF and cooled to -78 °C. A 1M solution of LSelectride  (2.2 mL, 2.2 mmol) was added dropwise and the reaction mixture was allowed to stir for 4 h. The reaction was quenched with water. After usual workup, the residue was purified by radial PLC to yield 462 mg (74%) of piperidone 13 as an oil. IR (thin film, neat, NaCl) 2932 (thin film, neat, NaCl) , 1711 (thin film, neat, NaCl) , 1504 (thin film, neat, NaCl) , 1416 (thin film, neat, NaCl) , 1205 ; 1 H NMR (CDCl 3 , 400 MHz, T = 55 °C) 7H), 7.16 (t, 1H, J = 7.2 Hz), 4H), 1H), 2H), 3H), 1H), 3.83 (s, 3H), 1H) 4, 154.4, 151.2, 149.5, 147.6, 136.9, 129.53, 129.46, 128.9, 128.8, 128.4, 128.2, 128.1, 127.5, 127.4, 125.7, 121.7, 121.5, 116.8, 116.4, 116.3, 116.12 and 116.08 (r), 115.4, 71.5 and 71.2 (r), 56.8 and 56.7 (r), 53.6 and 53.3 (r), 39.6 and 39.3 (r), 38.3 and 38.0 (r), 37.7, 31.4 and 30.3 (r) -2-bromo-4-methoxybenzyl)-4-oxo-3-(3-oxo-butyl)-piperidine-1-carboxylic acid phenyl ester (14) . The starting alkene 13 (462mg, 0.8 mmol) was dissolved in DMF/H 2 O (14 mL / 2 mL). Cu(OAc) 2 (30 mg, 0.17 mmol) and PdCl 2 (14 mg, 10 mol%) were then added. The resulting mixture was stirred under air for 2 h. The reaction mixture was quenched with water and extracted with ether. After usual workup the residue was purified by radial PLC to give 14 as an oil (268 mg 6, 136.8 and 136.7 (r), 129.5, 129.4, 129.2, 128.9, 128.8, 128.7, 128.2, 128.11, 128.08, 128.0, 127.5, 127.3, 125.7 and 125.6 (r), 121.7 and 121.5 (r), 116.7 and 116.3 (r) 4.2.14 1-(5-Benzyloxy-2-bromo-4-methoxybenzyl)-4a-hydroxy-6-oxo-octahydro isoquinoline-2-carboxylic acid phenyl ester (16). The starting diketone 14 (165 mg, 0.28 mmol) was dissolved in 10 mL of anhydrous THF and cooled to -5 °C. To this solution was added Ba(OH) 2 ·8H2O (17 mg, 0.055 mmol). The resulting mixture was allowed to stir for 2.5 h at -5 °C. TLC analysis at this point showed complete conversion of the starting material to the intermediate bicyclononane derivative 15. The temperature was then raised to 10 °C and an additional amount of Ba(OH) 2 8H 2 O (54 mg, 0.175 mmol) was added. After 2 h a TLC analysis showed the disappearance of the bicyclononane intermediate and formation of the bicyclic alcohol 17. Methanol was evaporated and the crude mixture was dissolved in methylene chloride. Water and aqueous NH 4 Cl were added and the pH was adjusted to neutrality. After usual workup, the residue was purified by radial PLC to yield compound 17, a white solid, as an inseparable 3:1 mixture of epimers in a 75% yield. Mp 168-169 °C; IR (thin film, neat, NaCl) 3438, 3064, 2949, 1694, 1504, 1416, 1207, 1162 cm -1 ; 1 H NMR (CDCl 3 , 400 MHz)  7.39-6.70 (mixed signals, 11H), 6.58 (d, 1H, J = 8.4 Hz), 5.14-4.99 (m, 2H), 4.76-4.73 (m, 0.75H, epimer 1), 4.50-4.48 (m, 0.25H, epimer 2), 4. 12-3.98 (m, 1H), 3.83-3.76 (m, 3H), 3.47-3.18 (m, 2H), 3.11-3.10 (m, 1H) , 2.93 (dd, 0.75H, J = 2.8 and 14.4 Hz), 2.55-2.20 (m, 6H), 2.03-1.68 (m, 3.6H), 1.33-1.30 (m, 0.75H); 13 C NMR (CDCl 3 , 100 MHz)  210. 9, 210.8, 207.9, 154.1, 153.3, 151.2, 151.0, 148.8, 148.6, 147.5, 147.1, 136.8, 136.7, 130.5, 130.2, 129.1, 128.9, 128.7, 128.5, 127.8, 127.1, 127.0, 125.0, 124.9, 124.7, 121.4, 121.2, 121.0, 117.2, 117.0, 116.2, 116.0, 115.5, 115.2, 73.0, 72.3, 71.5, 71.2, 71.1, 56.1, 55.5, 54.5, 53.6, 44.6, 44.2, 43.1, 41.3, 39.5, 39.3, 38.8, 38.3, 35.1, 34.3, 33.2, 32.8, 32.2, 27.2, 24.9, 24.8 1-(5-Benzyloxy-2-bromo-4-methoxybenzyl)-6-oxo-3,4,6,7,8,8a -hexahydro-1H-isoquinoline-2-carboxylic acid phenyl ester (2). The tertiary alcohol 16 (88 mg, 0.15 mmol) was dissolved in THF (5 mL) and cooled to 0 °C. A few drops of concentrated H 2 SO 4 were added and the reaction mixture was stirred at 0 °C. Careful monitoring by TLC and 1 H NMR showed that the minor isomer of the tertiary alcohol eliminated faster to yield the more polar product 17. The major isomer cyclized at a much slower rate to yield the less polar product. After 8 h at 0 °C, 20 mg of the major cis compound 2 (23%) and 11 mg of the minor trans compound 17 (13%) were isolated after usual workup and purification by radial PLC (SiO 2 , EtOAc/hexanes). The major isomer of the starting alcohol 16 was also recovered in 27% yield (24 mg 5, 129.3, 128.9, 128.8, 128.7, 128.2, 128.14, 128.09, 127.9, 127.6, 127.4, 127.2, 125.6 and 125.4 (r) + . The structure of compound 17 was confirmed by X-ray analysis.
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